Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study

Justin B. Echouffo-Tcheugui; Sui Zhang; Roberta Florido; Carine Hamo; James S. Pankow; Erin D. Michos; Ronald B. Goldberg; Vijay Nambi; Gary Gerstenblith; Wendy S. Post; Roger S. Blumenthal; Christie M. Ballantyne; Josef Coresh; Elizabeth Selvin; Chiadi E. Ndumele

doi:10.1016/j.jchf.2021.06.005

Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study

Justin B. Echouffo-Tcheugui, Sui Zhang, Roberta Florido, Carine Hamo, James S. Pankow, Erin D. Michos, Ronald B. Goldberg, Vijay Nambi, Gary Gerstenblith, Wendy S. Post, Roger S. Blumenthal, Christie M. Ballantyne, Josef Coresh, Elizabeth Selvin, Chiadi E. Ndumele

Epidemiology & Community Health

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

OBJECTIVES: This study assessed the association of diabetes duration with incident heart failure (HF).

BACKGROUND: Diabetes increases HF risk. However, the independent effect of diabetes duration on incident HF is unknown.

METHODS: We included 9,734 participants (mean age 63 years, 58% women, 22% Black) at ARIC (Atherosclerosis Risk In Communities) Visit 4 (1996-1998) without HF or coronary heart disease. We calculated diabetes duration at Visit 4 (baseline), utilizing diabetes status at the first 4 ARIC visits spaced 3 years apart, and self-reported diagnosis date for those with diabetes diagnosed before Visit 1. We used Cox regression to estimate associations of diabetes duration with incident HF, accounting for intercurrent coronary heart disease and other risk factors. We performed analyses stratified by age (<65 years or ≥65 years), race, sex, and glycemic control (hemoglobin A 1C [HbA 1C] consistently <7%, vs HbA 1C ≥7%), with tests for interaction.

RESULTS: Over 22.5 years of follow-up, there were 1,968 HF events. Compared to those without diabetes, HF risk rose with longer diabetes duration, with the highest risk among those with ≥15 y diabetes duration (HR: 2.82; 95% CI: 2.25-3.63). Each 5-year increase in diabetes duration was associated with a 17% (95% CI: 11-22) relative increase in HF risk. Similar results were observed across HF subtypes. The HF and diabetes duration associations were stronger among those aged <65 years, those with HbA 1C ≥7%, those with a body mass index ≥30 kg/m 2, women, and Blacks (all P interactions <0.05).

CONCLUSIONS: Delaying diabetes onset may augment HF prevention efforts, and therapies to improve HF outcomes might target those with long diabetes duration.

Original language	English (US)
Pages (from-to)	594-603
Number of pages	10
Journal	JACC: Heart Failure
Volume	9
Issue number	8
DOIs	https://doi.org/10.1016/j.jchf.2021.06.005
State	Published - Aug 2021

Bibliographical note

Funding Information:
The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), and Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr Tcheugui was supported by National Institutes of Health (NIH)/NHLBI grant K23 HL153774. Dr Hamo was supported by NIH/NHLBI grant number T32 HL007024. Dr Selvin was supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases grants K24 HL152440 and R01DK089174, and American Heart Association grant 20SFRN35120152. Dr Ndumele was supported by NIH grant R01HL146907 and American Heart Association grant 20SFRN35120152. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Publisher Copyright:
© 2021 American College of Cardiology Foundation

Keywords

duration of disease
heart failure
outcomes
risk
type 2 diabetes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.jchf.2021.06.005

Find It

Find It at U of M Libraries

Cite this

Echouffo-Tcheugui, J. B., Zhang, S., Florido, R., Hamo, C., Pankow, J. S., Michos, E. D., Goldberg, R. B., Nambi, V., Gerstenblith, G., Post, W. S., Blumenthal, R. S., Ballantyne, C. M., Coresh, J., Selvin, E., & Ndumele, C. E. (2021). Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study. JACC: Heart Failure, 9(8), 594-603. https://doi.org/10.1016/j.jchf.2021.06.005

Echouffo-Tcheugui, JB, Zhang, S, Florido, R, Hamo, C, Pankow, JS, Michos, ED, Goldberg, RB, Nambi, V, Gerstenblith, G, Post, WS, Blumenthal, RS, Ballantyne, CM, Coresh, J, Selvin, E & Ndumele, CE 2021, 'Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study', JACC: Heart Failure, vol. 9, no. 8, pp. 594-603. https://doi.org/10.1016/j.jchf.2021.06.005

@article{4d35e90f38df493a9557c6c5a70baf48,

title = "Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study",

abstract = "OBJECTIVES: This study assessed the association of diabetes duration with incident heart failure (HF).BACKGROUND: Diabetes increases HF risk. However, the independent effect of diabetes duration on incident HF is unknown.METHODS: We included 9,734 participants (mean age 63 years, 58% women, 22% Black) at ARIC (Atherosclerosis Risk In Communities) Visit 4 (1996-1998) without HF or coronary heart disease. We calculated diabetes duration at Visit 4 (baseline), utilizing diabetes status at the first 4 ARIC visits spaced 3 years apart, and self-reported diagnosis date for those with diabetes diagnosed before Visit 1. We used Cox regression to estimate associations of diabetes duration with incident HF, accounting for intercurrent coronary heart disease and other risk factors. We performed analyses stratified by age (<65 years or ≥65 years), race, sex, and glycemic control (hemoglobin A 1C [HbA 1C] consistently <7%, vs HbA 1C ≥7%), with tests for interaction. RESULTS: Over 22.5 years of follow-up, there were 1,968 HF events. Compared to those without diabetes, HF risk rose with longer diabetes duration, with the highest risk among those with ≥15 y diabetes duration (HR: 2.82; 95% CI: 2.25-3.63). Each 5-year increase in diabetes duration was associated with a 17% (95% CI: 11-22) relative increase in HF risk. Similar results were observed across HF subtypes. The HF and diabetes duration associations were stronger among those aged <65 years, those with HbA 1C ≥7%, those with a body mass index ≥30 kg/m 2, women, and Blacks (all P interactions <0.05). CONCLUSIONS: Delaying diabetes onset may augment HF prevention efforts, and therapies to improve HF outcomes might target those with long diabetes duration.",

keywords = "duration of disease, heart failure, outcomes, risk, type 2 diabetes",

author = "Echouffo-Tcheugui, {Justin B.} and Sui Zhang and Roberta Florido and Carine Hamo and Pankow, {James S.} and Michos, {Erin D.} and Goldberg, {Ronald B.} and Vijay Nambi and Gary Gerstenblith and Post, {Wendy S.} and Blumenthal, {Roger S.} and Ballantyne, {Christie M.} and Josef Coresh and Elizabeth Selvin and Ndumele, {Chiadi E.}",

note = "Funding Information: The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), and Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr Tcheugui was supported by National Institutes of Health (NIH)/NHLBI grant K23 HL153774. Dr Hamo was supported by NIH/NHLBI grant number T32 HL007024. Dr Selvin was supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases grants K24 HL152440 and R01DK089174, and American Heart Association grant 20SFRN35120152. Dr Ndumele was supported by NIH grant R01HL146907 and American Heart Association grant 20SFRN35120152. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} 2021 American College of Cardiology Foundation",

year = "2021",

month = aug,

doi = "10.1016/j.jchf.2021.06.005",

language = "English (US)",

volume = "9",

pages = "594--603",

journal = "JACC: Heart Failure",

issn = "2213-1779",

publisher = "Elsevier BV",

number = "8",

}

TY - JOUR

T1 - Duration of Diabetes and Incident Heart Failure

T2 - The ARIC (Atherosclerosis Risk In Communities) Study

AU - Echouffo-Tcheugui, Justin B.

AU - Zhang, Sui

AU - Florido, Roberta

AU - Hamo, Carine

AU - Pankow, James S.

AU - Michos, Erin D.

AU - Goldberg, Ronald B.

AU - Nambi, Vijay

AU - Gerstenblith, Gary

AU - Post, Wendy S.

AU - Blumenthal, Roger S.

AU - Ballantyne, Christie M.

AU - Coresh, Josef

AU - Selvin, Elizabeth

AU - Ndumele, Chiadi E.

N1 - Funding Information: The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), and Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr Tcheugui was supported by National Institutes of Health (NIH)/NHLBI grant K23 HL153774. Dr Hamo was supported by NIH/NHLBI grant number T32 HL007024. Dr Selvin was supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases grants K24 HL152440 and R01DK089174, and American Heart Association grant 20SFRN35120152. Dr Ndumele was supported by NIH grant R01HL146907 and American Heart Association grant 20SFRN35120152. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: © 2021 American College of Cardiology Foundation

PY - 2021/8

Y1 - 2021/8

N2 - OBJECTIVES: This study assessed the association of diabetes duration with incident heart failure (HF).BACKGROUND: Diabetes increases HF risk. However, the independent effect of diabetes duration on incident HF is unknown.METHODS: We included 9,734 participants (mean age 63 years, 58% women, 22% Black) at ARIC (Atherosclerosis Risk In Communities) Visit 4 (1996-1998) without HF or coronary heart disease. We calculated diabetes duration at Visit 4 (baseline), utilizing diabetes status at the first 4 ARIC visits spaced 3 years apart, and self-reported diagnosis date for those with diabetes diagnosed before Visit 1. We used Cox regression to estimate associations of diabetes duration with incident HF, accounting for intercurrent coronary heart disease and other risk factors. We performed analyses stratified by age (<65 years or ≥65 years), race, sex, and glycemic control (hemoglobin A 1C [HbA 1C] consistently <7%, vs HbA 1C ≥7%), with tests for interaction. RESULTS: Over 22.5 years of follow-up, there were 1,968 HF events. Compared to those without diabetes, HF risk rose with longer diabetes duration, with the highest risk among those with ≥15 y diabetes duration (HR: 2.82; 95% CI: 2.25-3.63). Each 5-year increase in diabetes duration was associated with a 17% (95% CI: 11-22) relative increase in HF risk. Similar results were observed across HF subtypes. The HF and diabetes duration associations were stronger among those aged <65 years, those with HbA 1C ≥7%, those with a body mass index ≥30 kg/m 2, women, and Blacks (all P interactions <0.05). CONCLUSIONS: Delaying diabetes onset may augment HF prevention efforts, and therapies to improve HF outcomes might target those with long diabetes duration.

AB - OBJECTIVES: This study assessed the association of diabetes duration with incident heart failure (HF).BACKGROUND: Diabetes increases HF risk. However, the independent effect of diabetes duration on incident HF is unknown.METHODS: We included 9,734 participants (mean age 63 years, 58% women, 22% Black) at ARIC (Atherosclerosis Risk In Communities) Visit 4 (1996-1998) without HF or coronary heart disease. We calculated diabetes duration at Visit 4 (baseline), utilizing diabetes status at the first 4 ARIC visits spaced 3 years apart, and self-reported diagnosis date for those with diabetes diagnosed before Visit 1. We used Cox regression to estimate associations of diabetes duration with incident HF, accounting for intercurrent coronary heart disease and other risk factors. We performed analyses stratified by age (<65 years or ≥65 years), race, sex, and glycemic control (hemoglobin A 1C [HbA 1C] consistently <7%, vs HbA 1C ≥7%), with tests for interaction. RESULTS: Over 22.5 years of follow-up, there were 1,968 HF events. Compared to those without diabetes, HF risk rose with longer diabetes duration, with the highest risk among those with ≥15 y diabetes duration (HR: 2.82; 95% CI: 2.25-3.63). Each 5-year increase in diabetes duration was associated with a 17% (95% CI: 11-22) relative increase in HF risk. Similar results were observed across HF subtypes. The HF and diabetes duration associations were stronger among those aged <65 years, those with HbA 1C ≥7%, those with a body mass index ≥30 kg/m 2, women, and Blacks (all P interactions <0.05). CONCLUSIONS: Delaying diabetes onset may augment HF prevention efforts, and therapies to improve HF outcomes might target those with long diabetes duration.

KW - duration of disease

KW - heart failure

KW - outcomes

KW - risk

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85110321659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110321659&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2021.06.005

DO - 10.1016/j.jchf.2021.06.005

M3 - Article

C2 - 34325890

AN - SCOPUS:85110321659

SN - 2213-1779

VL - 9

SP - 594

EP - 603

JO - JACC: Heart Failure

JF - JACC: Heart Failure

IS - 8

ER -

Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this